Search Results

There are 5340 results for: content related to: Study of medication-free children with Tourette syndrome do not show imaging abnormalities

  1. The focal dystonias: Current views and challenges for future research

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 926–943, H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter, Ami R. Rosen and for the Dystonia Coalition Investigators

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25567

  2. Neuropathology of multiple system atrophy: New thoughts about pathogenesis

    Movement Disorders

    Volume 29, Issue 14, December 2014, Pages: 1720–1741, Kurt A. Jellinger

    Version of Record online : 9 OCT 2014, DOI: 10.1002/mds.26052

  3. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 861–881, Manuel Delgado-Alvarado, Belén Gago, Irene Navalpotro-Gomez, Haritz Jiménez-Urbieta and María C. Rodriguez-Oroz

    Version of Record online : 19 MAY 2016, DOI: 10.1002/mds.26662

  4. The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

    Movement Disorders

    Volume 31, Issue 8, August 2016, Pages: 1080–1094, Raul Martínez-Fernández, Emmanuelle Schmitt, Pablo Martinez-Martin and Paul Krack

    Version of Record online : 19 JUL 2016, DOI: 10.1002/mds.26731

  5. “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide

    Movement Disorders

    Volume 28, Issue 9, August 2013, Pages: 1184–1199, Maria Stamelou, Niall P. Quinn and Kailash P. Bhatia

    Version of Record online : 29 MAY 2013, DOI: 10.1002/mds.25509

  6. You have free access to this content
    The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease

    Movement Disorders

    Volume 31, Issue 1, January 2016, Pages: 23–38, Gretchen O. Reynolds, Michael W. Otto, Terry D. Ellis and Alice Cronin-Golomb

    Version of Record online : 30 DEC 2015, DOI: 10.1002/mds.26484

  7. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force

    Movement Disorders

    Volume 31, Issue 4, April 2016, Pages: 436–457, Connie Marras, Anthony Lang, Bart P. van de Warrenburg, Carolyn M. Sue, Sarah J. Tabrizi, Lars Bertram, Saadet Mercimek-Mahmutoglu, Darius Ebrahimi-Fakhari, Thomas T. Warner, Alexandra Durr, Birgit Assmann, Katja Lohmann, Vladimir Kostic and Christine Klein

    Version of Record online : 15 APR 2016, DOI: 10.1002/mds.26527

  8. The anatomical basis of dystonia: Current view using neuroimaging

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 944–957, Stéphane Lehéricy, Marina A.J. Tijssen, Marie Vidailhet, Ryuji Kaji and Sabine Meunier

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25527

  9. Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders

    Movement Disorders

    Volume 30, Issue 9, August 2015, Pages: 1155–1170, Léon Tremblay, Yulia Worbe, Stéphane Thobois, Véronique Sgambato-Faure and Jean Féger

    Version of Record online : 15 MAR 2015, DOI: 10.1002/mds.26199

  10. You have free access to this content
    Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 848–860, Steffen Halbgebauer, Patrick Öckl, Katharina Wirth, Petra Steinacker and Markus Otto

    Version of Record online : 2 MAY 2016, DOI: 10.1002/mds.26635

  11. Behavioral effects of levodopa

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 90–102, Isabelle Beaulieu-Boire and Anthony E. Lang

    Version of Record online : 9 DEC 2014, DOI: 10.1002/mds.26121

  12. Psychiatric issues in cognitive impairment

    Movement Disorders

    Volume 29, Issue 5, 15 April 2014, Pages: 651–662, Dag Aarsland, John-Paul Taylor and Daniel Weintraub

    Version of Record online : 22 APR 2014, DOI: 10.1002/mds.25873

  13. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases—From pathophysiology to clinical practice

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 836–847, Kaj Blennow, Leonardo Biscetti, Paolo Eusebi and Lucilla Parnetti

    Version of Record online : 4 MAY 2016, DOI: 10.1002/mds.26656

  14. Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease

    Movement Disorders

    Volume 30, Issue 8, July 2015, Pages: 1014–1025, Marc Deffains and Hagai Bergman

    Version of Record online : 22 JUN 2015, DOI: 10.1002/mds.26300

  15. Probing striatal microcircuitry to understand the functional role of cholinergic interneurons

    Movement Disorders

    Volume 30, Issue 10, September 2015, Pages: 1306–1318, Allison E. Girasole and Alexandra B. Nelson

    Version of Record online : 30 JUL 2015, DOI: 10.1002/mds.26340

  16. The therapeutic potential of cannabinoids for movement disorders

    Movement Disorders

    Volume 30, Issue 3, March 2015, Pages: 313–327, Benzi Kluger, Piera Triolo, Wallace Jones and Joseph Jankovic

    Version of Record online : 4 FEB 2015, DOI: 10.1002/mds.26142

  17. Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?

    Movement Disorders

    Volume 29, Issue 11, 15 September 2014, Pages: 1404–1413, Annie Killoran and Kevin M. Biglan

    Version of Record online : 27 AUG 2014, DOI: 10.1002/mds.26014

  18. Tourette syndrome deep brain stimulation: A review and updated recommendations

    Movement Disorders

    Volume 30, Issue 4, April 2015, Pages: 448–471, Lauren E. Schrock, Jonathan W. Mink, Douglas W. Woods, Mauro Porta, Dominico Servello, Veerle Visser-Vandewalle, Peter A. Silburn, Thomas Foltynie, Harrison C. Walker, Joohi Shahed-Jimenez, Rodolfo Savica, Bryan T. Klassen, Andre G. Machado, Kelly D. Foote, Jian-Guo Zhang, Wei Hu, Linda Ackermans, Yasin Temel, Zoltan Mari, Barbara K. Changizi, Andres Lozano, M. Auyeung, Takanobu Kaido, Yves Agid, Marie L. Welter, Suketu M. Khandhar, Alon Y. Mogilner, Michael H. Pourfar, Benjamin L. Walter, Jorge L. Juncos, Robert E. Gross, Jens Kuhn, James F. Leckman, Joseph A Neimat, Michael S. Okun and on behalf of the Tourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group

    Version of Record online : 5 DEC 2014, DOI: 10.1002/mds.26094

  19. Biomarkers for trials of neuroprotection in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 1, January 2013, Pages: 71–85, Pankaj A. Agarwal and A. Jon Stoessl

    Version of Record online : 24 AUG 2012, DOI: 10.1002/mds.25065

  20. The neurobiological basis of cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 29, Issue 5, 15 April 2014, Pages: 634–650, Glenda M. Halliday, James B. Leverenz, Jay S. Schneider and Charles H. Adler

    Version of Record online : 22 APR 2014, DOI: 10.1002/mds.25857